IMMUNOMICS LAB
LATEST PROJECTS
FLAMIN–GO
The EU funded research project FLAMIN-GO aims at developing the firs customized joint-on-chip. Such construct is able to recreate, starting from each patient’s biopsies, a three-dimensional in vitro model of the joint of the patient affected by rheumatoid arthritis (RA), for the personalized study of an effective therapy.
FORCE REPAIR
FORCE REPAIR aims to advance chronic wound management by developing a smart, multifunctional, and cost-effective 3D-printed wound dressing that effectively combats bacterial infections and inflammation, promotes healing, and relieves skin tension.
SINPAIN
SINPAIN aims to develop a pipeline of siRNA-based therapy built on the combination of current technologies (dynamic IA-HA and nanocarriers) that will be designed step- by-step in order to reach a successful management of inflammation and innervation therapy for the treatment of early (grade 0-1) and later stages (grade 3-4) of knee OA.
WE DIVE IN DEEP
Our vision is to revolutionize healthcare changing the way we diagnose and treat autoimmune diseases, moving from a trial-and-error approach to a data-driven, precise and highly accurate model-based approach.
This will be achieved through the integration of on-frontiers technologies such as advanced flow and mass cytometry, immunomics, and organ-on-chip models to uncover early biomarkers of autoimmune diseases and drive customized treatment approaches.
PROJECT, RESEARCH, INNOVATE
The Immunomics Lab is dedicated to advancing the comprehension of autoimmune disorders and providing individualized treatments through state-of-the-art technologies, excellence, and engagement of top-tier professionals.
By cytomics and transcriptomics, we are developing high-throughput biomedical assays capable of generating vast amounts of patient-specific data, with the aim to uncover early biomarkers of autoimmune diseases and provide new insights into their pathophysiologic mechanisms. In addition to multi-omics techniques, we harness the power of organ-on-chip technology to recreate the microenvironment of human organs, providing a platform for studying disease mechanisms and drug responses with unprecedented fidelity, enabling more accurate and personalized medicine.
We are committed to collaborate with clinicians and industries to drive scientific innovation, cultivate emerging talent in immunology, and share our accomplishments to advance scientific knowledge dissemination, with the ultimate goal of improving patient outcomes.
The Immunomics Lab is committed to ensure the widespread dissemination of its research findings and insights with the scientific community and the general public. Through publications, collaborative workshops, and educational initiatives, we aim to raise awareness about autoimmune diseases, promote dialogue among stakeholders, and contribute to the advancement of immunological knowledge globally.
IMMUNOMICS LAB
LATEST PROJECTS
FLAMIN–GO
The EU funded research project FLAMIN-GO aims at developing the firs customized joint-on-chip. Such construct is able to recreate, starting from each patient’s biopsies, a three-dimensional in vitro model of the joint of the patient affected by rheumatoid arthritis (RA), for the personalized study of an effective therapy.
FORCE REPAIR
FORCE REPAIR aims to advance chronic wound management by developing a smart, multifunctional, and cost-effective 3D-printed wound dressing that effectively combats bacterial infections and inflammation, promotes healing, and relieves skin tension.
SINPAIN
SINPAIN aims to develop a pipeline of siRNA-based therapy built on the combination of current technologies (dynamic IA-HA and nanocarriers) that will be designed step- by-step in order to reach a successful management of inflammation and innervation therapy for the treatment of early (grade 0-1) and later stages (grade 3-4) of knee OA.
WE DIVE IN DEEP
Our vision is to revolutionize healthcare changing the way we diagnose and treat autoimmune diseases, moving from a trial-and-error approach to a data-driven, precise and highly accurate model-based approach.
This will be achieved through the integration of on-frontiers technologies such as advanced flow and mass cytometry, immunomics, and organ-on-chip models to uncover early biomarkers of autoimmune diseases and drive customized treatment approaches.
PROJECT, RESEARCH, INNOVATE
The Immunomics Lab is dedicated to advancing the comprehension of autoimmune disorders and providing individualized treatments through state-of-the-art technologies, excellence, and engagement of top-tier professionals.
By cytomics and transcriptomics, we are developing high-throughput biomedical assays capable of generating vast amounts of patient-specific data, with the aim to uncover early biomarkers of autoimmune diseases and provide new insights into their pathophysiologic mechanisms. In addition to multi-omics techniques, we harness the power of organ-on-chip technology to recreate the microenvironment of human organs, providing a platform for studying disease mechanisms and drug responses with unprecedented fidelity, enabling more accurate and personalized medicine.
We are committed to collaborate with clinicians and industries to drive scientific innovation, cultivate emerging talent in immunology, and share our accomplishments to advance scientific knowledge dissemination, with the ultimate goal of improving patient outcomes.
The Immunomics Lab is committed to ensure the widespread dissemination of its research findings and insights with the scientific community and the general public. Through publications, collaborative workshops, and educational initiatives, we aim to raise awareness about autoimmune diseases, promote dialogue among stakeholders, and contribute to the advancement of immunological knowledge globally.